Would CPT code 81420 , 81507 , or 81599 be the correct code for reporting a prenatal screen test for fetal aneuploidy that utilizes GSP and an algorithm, but is not listed under any of the MAAA categories? ...
Subscribe or sign in to view the full article.
Article Overview
This article addresses a prenatal screening coding question in the context of CPT multianalyte assay with algorithmic analysis reporting. It is aimed at coders and billers who work with prenatal genetics, molecular diagnostics, and laboratory test reporting, and it discusses when a service may fall within a listed MAAA category versus an unlisted assay category.
Why This Topic Matters
Prenatal genetic screening tests are frequently proprietary and method-specific, so correct code selection depends on how the test is categorized within CPT guidance. Understanding the article helps coders recognize the reporting framework used for these assays and identify when a test may be considered outside a listed MAAA descriptor.
What You Will Learn
- How a prenatal fetal aneuploidy screening test is evaluated within the CPT MAAA framework.
- What general factors affect whether a test is treated as a listed assay category or an unlisted assay category.
- How the article frames the relationship between algorithm-based reporting and genomic sequencing-based prenatal testing.
- intended_audiences_,
Who Should Read This
- Medical coders
- Billing staff
- Laboratory coding specialists
- Prenatal genetics practices
- Molecular pathology professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com